Recent Resident Publications

Lightfoot AJ, Breyer BN, Rosevear HM, Erickson BA, Konety BR, O'Donnell MA. Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer. Urol Oncol. 2013 Mar 16. doi:pii: S1078-1439(13)00045-8. 10.1016/j.urolonc.2013.01.009. [Epub ahead of print] PubMed PMID: 23510863.

Lightfoot AJ, Rosevear HM, Nepple KG, O'Donnell MA. Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer. Int J Urol. 2012 Nov;19(11):988-93. doi: 10.1111/j.1442-2042.2012.03089.x. Epub 2012 Jul 4. PubMed PMID: 22762480.

Norian LA, Kresowik TP, Rosevear HM, James BR, Rosean TR, Lightfoot AJ, Kucaba TA, Schwarz C, Weydert CJ, Henry MD, Griffith TS. Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy. PLoS One. 2012;7(2):e31085. doi: 10.1371/journal.pone.0031085. Epub 2012 Feb 1. PubMed PMID: 22312440; PubMed Central PMCID: PMC3270031.

Rosevear HM, Krishnamachari Y, Ariza CA, Mallapragada SK, Salem AK, Griffith TS, De Young BR, Wald M. Effect of combined locally delivered growth factors and systemic sildenafil citrate on microrecanalization in biodegradable conduit for vas deferens reconstruction. Urology. 2012 Apr;79(4):967.e1-4. doi: 10.1016/j.urology.2011.11.030. Epub 2012 Jan 27. PubMed PMID: 22285175.

Rosevear HM, Lightfoot AJ, Birusingh KK, Maymí JL, Nepple KG, O'Donnell MA; National BCG/Interferon Investigator Group. Factors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situ. J Urol. 2011 Sep;186(3):817-23. doi: 10.1016/j.juro.2011.04.073. Epub 2011 Jul 23. PubMed PMID: 21788050.

Rosevear HM, Gellhaus PT, Lightfoot AJ, Kresowik TP, Joudi FN, Tracy CR. Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk. BJU Int. 2012 Mar;109(5):700-5. doi: 10.1111/j.1464-410X.2011.10452.x. Epub 2011 Jul 20. PubMed PMID: 21777362.

Nepple KG, Rosevear HM, Stolpen AH, Brown JA, Williams RD. Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients. Urol Oncol. 2011 Jun 10. [Epub ahead of print] PubMed PMID: 21665495.

Lightfoot AJ, Rosevear HM, Steers WD, Tracy CR. Current and future need for academic urologists in the United States. J Urol. 2011 Jun;185(6):2283-7. doi: 10.1016/j.juro.2011.02.058. Epub 2011 Apr 17. PubMed PMID: 21497844.

Lightfoot AJ, Rosevear HM, O'Donnell MA. Recognition and treatment of BCG failure in bladder cancer. ScientificWorldJournal. 2011 Mar 7;11:602-13. doi: 10.1100/tsw.2011.30. PubMed PMID: 21399857.

Bockholt NA, Knudson MJ, Henning JR, Maymí JL, Weady P, Smith GJ, Eisenbraun MD, Fraser JD, O'Donnell MA, Luo Y. Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer. J Urol. 2012 Jun;187(6):2228-35. doi: 10.1016/j.juro.2012.01.030. Epub 2012 Apr 13. PubMed PMID: 22503050.

Cooper CS, Birusingh KK, Austin JC, Knudson MJ, Brophy PD. Distal ureteral diameter measurement objectively predicts vesicoureteral reflux outcome. J Pediatr Urol. 2013 Feb;9(1):99-103. doi: 10.1016/j.jpurol.2011.12.011. Epub 2012 Jan 9. PubMed PMID: 22236467.

Bockholt NA, Wild TT, Gupta A, Tracy CR. Ureteric stent placement with extraction string: no strings attached? BJU Int. 2012 Dec;110(11 Pt C):E1069-73. doi: 10.1111/j.1464-410X.2012.11219.x. Epub 2012 May 11. PubMed PMID: 22578135.

Askeland EJ, Arlen AM, Erickson BA, Mathews KD, Cooper CS. Urologic Manifestations in Duchenne Muscular Dystrophy. J Urol. 2013 Jan 25. doi:pii: S0022-5347(13)00095-5. 10.1016/j.juro.2013.01.059. [Epub ahead of print] PubMed PMID: 23357214.

Askeland EJ, Newton MR, O'Donnell MA, Luo Y. Bladder Cancer Immunotherapy: BCG and Beyond. Adv Urol. 2012;2012:181987. doi: 10.1155/2012/181987. Epub 2012 Jun 20. PubMed PMID: 22778725; PubMed Central PMCID: PMC3388311.

James BR, Tomanek-Chalkley A, Askeland EJ, Kucaba T, Griffith TS, Norian LA. Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J Immunol. 2012 Aug 1;189(3):1311-21. doi: 10.4049/jimmunol.1100587. Epub 2012 Jun 27. PubMed PMID: 22745381; PubMed Central PMCID: PMC3401274.

Thurmon KL, Breyer BN, Erickson BA. Association of bowel habits with lower urinary tract symptoms in men: findings from the 2005-2006 and 2007-2008 national health and nutrition examination survey. J Urol. 2013 Apr;189(4):1409-14. doi: 10.1016/j.juro.2012.10.008. Epub 2012 Oct 11. PMID: 23063806.

Barnes KT, Smith BJ, Lynch CF, Gupta A. Obesity and invasive penile cancer. Eur Urol. 2013 Mar;63(3):588-9. doi: 10.1016/j.eururo.2012.11.046. Epub 2012 Nov 27. PMID: 23219085.

Gillespie JA, O'Donnell MA. New imaging techniques for non-muscle invasive bladder cancer: ready for primetime. Urol Clin North Am. 2013 May;40(2):271-9. doi: 10.1016/j.ucl.2013.01.014. Epub 2013 Mar 7. PMID: 23540784.

We'd welcome your feedback!

Please help us improve your experience on our website by completing a brief survey